Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial?

Estimated read time 2 min read

Stockhead’s Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.

The S&P/ASX200 is up today, gaining 10.60 points or 0.14% to 7,744.10 at 10.30am (AEDT).

 

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code Description Last % Volume MktCap CNJ Conico Ltd 0.003 50% 517,500 $3,140,190 M4M Macro Metals Limited 0.006 50% 22,335,306 $11,248,311 ADG Adelong Gold Limited 0.004 33% 1,372,904 $2,153,967 AVE Avecho Biotech Ltd 0.004 33% 3,414,634 $9,507,891 LSR Lodestar Minerals 0.002 33% 5,000,000 $3,035,096 HVY Heavy Minerals 0.105 30% 160,273 $4,667,509 ICE Icetana Limited 0.035 25% 143,882 $7,409,596 EDE Eden Inv Ltd 0.0025 25% 232,732 $7,356,542 CVR Cavalier Resources 0.115 21% 27,776 $3,023,747 VAL Valor Resources Ltd 0.003 20% 166,666 $11,472,533

WordPress Table Plugin

 

Avecho (ASX:AVE) has announced that Phase 3 clinical trial testing of its oral CBD TPM-enhanced soft-gel capsule for insomnia has gained final ethics approval.

AVE says patient recruitment for the pivotal trial is on track to start this month for clinical trial sites in Melbourne, Sydney, Central Coast, Brisbane, and Perth.

Heavy Minerals (ASX:HVY) has inked a non-binding Memorandum of Understanding (MOU) for the future sales of a minimum of 15,000 tpa of garnet to be produced at its Port Gregory Project in Western Australia for an initial three-year period with ABSS.

HVY says the offtake will account for ~10% of the company’s annual future Garnet production at its Port Gregory Project and will be sold into the Australian and New Zealand sand blasting and water jet cutting markets by ABSS.

 

LOSERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code Company Price % Volume Market Cap AXP AXP Energy Ltd 0.001 -50% 3,789,544 $11,649,361 VPR Volt Power Group 0.001 -50% 343,790 $21,432,416 SIH Sihayo Gold Limited 0.001 -33% 3,334 $18,306,384 1MC Morella Corporation 0.003 -25% 416,129 $24,715,198 RIE Riedel Resources Ltd 0.003 -25% 31,731 $8,895,343 EPX EPT Global Limited 0.02 -20% 4,500 $14,693,606 AUK Aumake Limited 0.003 -14% 15,224 $6,700,424 POS Poseidon Nick Ltd 0.007 -13% 285,244 $29,708,278 KNI Kuniko Ltd 0.21 -11% 11,000 $20,314,403 CZN Corazon Ltd 0.009 -10% 10,750 $6,155,979

WordPress Table Plugin

The post Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial? appeared first on Stockhead.

You May Also Like